Determination of the Compound Biological Effectiveness (CBE) Factors based on the ISHIYAMA-IMAHORI Deterministic Parsing Model with the Dynamic PET Technique

Authors

  • Shintaro Ishiyama

  • Yoshio Imahori

  • Jun Itami

  • Hanna Koivunoro

Keywords:

boron neutron capture therapy, compound biological effectiveness, borono-phenylalanine, tumor, 10B(n, #x3B1;)7 li, sigmoid function

Abstract

Purpose: In defining the biological effects of the 10B (n, α)7Li neutron capture reaction, we have proposed a deterministic parsing model (ISHIYAMA-IMAHORI model) to determine the Compound Biological Effectiveness (CBE) factor in Borono-Phenyl-Alanine (BPA)-mediated Boron Neutron Capture Therapy (BNCT). In present paper, we Where, Nth and Nmax are the threshold value of boron concentration of N and saturation boron density and CBE0, F and n are given as 0.5, 8 and 3, respectively. In order to determine Nth and Nmax in the formula, sigmoid logistic function was employed for 10B concentration data, Db(t) obtained by dynamic PET technique. (2) Where, A, a and t0 are constants Results and Conclusion: From the application of sigmoid function to dynamic PET data, it is concluded that the Nth and Nmax for tissue and tumor are identified with the parameter constants in the sigmoid function in eq.(2) as; (3) And the calculated CBE factor values obtained from eq. (1), with Nth/Nmax.

How to Cite

Determination of the Compound Biological Effectiveness (CBE) Factors based on the ISHIYAMA-IMAHORI Deterministic Parsing Model with the Dynamic PET Technique. (2015). Global Journal of Medical Research, 15(30), 1-5. https://medicalresearchjournal.org/index.php/GJMR/article/view/

Author Biography

Shintaro Ishiyama

Shintaro Ishiyama is a researcher affiliated with the Japan Atomic Energy Agency (JAEA) at the Quantum Beam Science Center in Tokai-mura, Ibaraki, Japan, and also associated with Helsinki University Central Hospital. His work focuses on the development of deterministic parsing models for the Compound Biological Effectiveness (CBE) factor in Boron Neutron Capture Therapy (BNCT), particularly in relation to intracellular 10Boron distribution. He has contributed to advancing the understanding of BNCT through dynamic PET techniques, aiming to improve the precision of radiation therapy for cancer treatment.

References

B. Bayanov, V. Belov, V. Kindyuk, E. Oparin, S. Taskaev (1999) Lithium neutron producting target for 8. Coderre J.A. and G.M. Morris; "The irradiation biology of boron neutron capture therapy. 151, 1-18.

GM, J.A.Coderre, J.W.Hopewell, P.L.Micca, M. Rezvani (1989) Response of the skin to boron neutron capture therapy with pboronopenylalanine or borocaptate sodium. 39, 253-259.

W. JL, K. Kiger, P. Riley, H. Binns, J. Patel, O. Hopewell, P. Harling, J. Busse, Coderre, M. Suzuki, S. Masunaga, Y. Kinachi, M. Takagai, Y. Sakurai, T. Kobayashi, K. Ono, Y. Imahori (1998) Positron emission tomographybased boron neutron capture therapy using boronophenylalanine for high-grade gliomas: part II. 171(1), 1833-1841.

Determination of the Compound Biological Effectiveness (CBE) Factors based on the ISHIYAMA-IMAHORI Deterministic Parsing Model with the Dynamic PET Technique

Published

2015-08-28

How to Cite

Determination of the Compound Biological Effectiveness (CBE) Factors based on the ISHIYAMA-IMAHORI Deterministic Parsing Model with the Dynamic PET Technique. (2015). Global Journal of Medical Research, 15(30), 1-5. https://medicalresearchjournal.org/index.php/GJMR/article/view/